Are Transfusions a Barrier to High-Quality End-of-Life Care in Hematology?
Dr. LeBlanc and Dr. Litzow take a look at an issue within the field consisting of hematologists referring their patients to hospice late or not at all even when there are s
Venous Thrombosis on One Side and Bleeding on the Other: How to Walk the Fence in Cancer Patients With Thrombosis and Thrombocytopenia
Dr. Linkins provides guidance on how to manage recurrent thrombosis and bleeding in a cancer patient with severe thrombocytopenia that develops VTE.
Expert opinion focused on challenging diagnostic and management issues
Dr. Sweet presents the case of a 48-year-old woman with chronic-phase chronic myeloid leukemia being treated effectively with imatinib, and contemplates whether the patient is a candidate for a trial of tyrosine kinase inhibitor cessation.
Dr. Lazarus and Dr. Ljungman discuss the optimal approach to prevent cytomegalovirus infection in patients undergoing allogeneic hematopoietic cell transplantation in 2018.
Dr. Lisa Baumann Kreuziger recommends an approach to antithrombotic therapy management in adults undergoing left ventricular assist device placement.
Drs. Miles Conrad, Melissa Dickey, Steven Hetts and Andrew Leavitt discuss approaches to hereditary hemorrhagic telangiectasia.
Drs. Andrea Baines and Ann Farrell explain the process of obtaining an investigational agent outside of a clinical trial through expanded access programs.
Dr. Moss evaluates a case that requires CAR-T cell therapy and discusses practical issues hematologists should be aware of during introduction of this treatment.
Dr. Hausdorff discusses use of the SPIKES protocol to more efficiently deliver bad news to patients and their families.
Dr. Berube and Dr. Dietrich discuss their approach to the diagnosis and management of von Willebrand disease during pregnancy.
Dr. Stieglitz and Dr. Koegel discuss genetic markers and risk stratification algorithms to guide individualized treatment of juvenile myelomonocytic leukemia.
Dr. Dunbar and Dr. Shaz look at indications for therapeutic plasma exchange (TPE) in the setting of thrombotic microangiopathy (TMA).
July-August 2018Volume 15, Issue 4
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology